









Markets
/
Stocks
/
nasdaq-mdt
/

Medtronic PLC

MDT



View Detailed Chart

93.460USD

-0.570-0.61%

Market hours （ET）Quotes delayed by 15 min

119.80BMarket Cap

25.71P/E TTM



Medtronic PLC

93.460

-0.570-0.61%

Overview Company Financials Analysis

Analysis

Intraday

30m

Today

-0.61%

5 Days

+0.60%

1 Month

+1.61%

6 Months

+0.42%

Year to Date

+17.00%

1 Year

+3.84%

View Detailed Chart

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

14 / 207

Overall Ranking

107 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 35 analysts

Buy

Current Rating

98.585

Target Price

+4.84%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 33.54B.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 24.06.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.

Fairly Valued

The company’s latest PE is 25.89, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.12B shares, decreasing 1.59% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 126.32M shares of this stock.

News

[IN-DEPTH ANALYSIS] Riding the Wave: How Medtronic Capitalizes on the Aging Population

TradingKey - Against the backdrop of the global aging trend and the continuous rise in the incidence of chronic diseases, Medtronic's product portfolio precisely meets the growing demand for diagnosis and treatment. Relying on its global supply chain network and years of accumulated technological...

TradingKeyMon, May 26